Counselors in Morro Bay, CA Accepting Medicare

10 Counselors found. Showing 1 - 10

Marshall King Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 895 Napa Ave Ste B2, Morro Bay, CA 93442 Phone: 805-801-1036

Kimberly Meyer Counselor Medicare: Not Enrolled in Medicare Practice Location: 175 Kern Ave, Morro Bay, CA 93442 Phone: 805-801-8045

Richard Lincoln Donald V, RADT Counselor Medicare: Not Enrolled in Medicare Practice Location: 2460 Main St, Morro Bay, CA 93442 Phone: 805-888-9619

Zachary J Lepard Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2690 Juniper Ave, Morro Bay, CA 93442 Phone: 406-431-8114

David H Musoloff Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 417 Monterey Ave, Morro Bay, CA 93442 Phone: 805-781-3535

Lillian Macari, LAADC, RAS, FAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 895 Napa Ave, Suite # A6, Morro Bay, CA 93442 Phone: 805-225-1471    Fax: 805-225-1472

Jill Diane Garman, LCSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 895 Napa Ave, Suite B-6, Morro Bay, CA 93442 Phone: 805-704-1679

Jennifer Myra Marie Van Beurden, R1464360322 Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2460 Main St, Morro Bay, CA 93442 Phone: 805-235-5615

April Lynn Nunez, LMFT Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 485 Morro Bay Blvd Ste 108, Morro Bay, CA 93442 Phone: 805-316-0699

Emily Elrod-black, MA, APCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1181 Main St, Morro Bay, CA 93442 Phone: 650-207-3557

News Archive

New antidepressants might be no more effective than the best existing drugs

The reviews suggest that sertraline - sold under the brand name Zoloft since 1991- could be the best initial choice of antidepressant in people with acute major depression. The generic formulation produced the best balance of effectiveness, tolerability and purchase price, the authors say.

Positive results from VIVUS' Phase 3 study of avanafil for ED in men with diabetes

VIVUS, Inc. today announced positive results from the phase 3 REVIVE-Diabetes (TA-302) study, evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED) in men with type 1 and type 2 diabetes. The REVIVE-Diabetes study met all three primary endpoints across the two doses studied by demonstrating statistically significant improvement in erectile function as measured by the Sexual Encounter Profile (SEP) and improvements in the International Index of Erectile Function (IIEF) score.

eRNA molecules are key players in brain development, says study

How does the brain work? This question is one of the greatest scientific mysteries, and neurobiologists have only recently begun to piece together the molecular building blocks that enable human beings to be "thinking" animals.

CHLA participates in clinical trial using stem cells to treat rare congenital heart defect

Children's Hospital Los Angeles is announcing participation in the first-ever clinical trial using stem cells from umbilical cord blood to delay or even prevent heart failure in children born with a rare congenital heart defect that leaves them with half a heart.

Combination of SYK and FLT3 enzymes promotes progression of acute myelogenous leukemia

Reinforcing the need to look beyond genomic alterations to understand the complexity of cancer, researchers from Dana-Farber/Boston Children's Cancer and Blood Disorders Center report that a normal enzyme called SYK pairs with FLT3, the most commonly mutated enzyme found in acute myelogenous leukemia (AML), to promote progression of the disease.

Read more Medical News

› Verified 5 days ago